93% of Delhi Residents Had Zika Antibodies. The Real Story Is Subtler
A Lancet Regional Health Southeast Asia study published on 10 November 2026 found Zika-binding antibodies in 92.7% of healthy Delhi residents, but cross-reactivity with dengue complicates the headline. We explain what the numbers do and do not show.
Editor's picks
See all
Your Government Wants to Tell You Your Biological Age. Can It?
Abu Dhabi is putting an AI biological age score on a government app. Its own standard says such clocks still need validation.
Shuffle the Test Set and Protein AI's Best Scores Collapse
AI Agents Just Ran a DNA Lab for 11,000 Steps With Almost No Humans
Western Ethics Wrote AI's Medical Rulebook. Yoruba Philosophy Answers Back
The Next Pandemic Won't Have the Symptoms You're Watching For
AI
See all
Virology
See all
Recent posts
See all
AI Models Cells Across a Billion Years. Can They Beat Plain PCA?
A preprint posted last week shows single-cell foundation models transfer across a billion years of evolution. The peer-reviewed benchmark record is far less flattering. Here is what the evidence actually supports.
Just Describe the Protein You Want. This AI Builds It, and It Works
A protein language model called Pinal designs working enzymes from plain-English prompts. What the Nature paper proves, and what it does not.
Measles Elimination Now Hinges on 450 Letters of Viral Code
This month PAHO decides whether the United States and Mexico have lost measles elimination status. The verdict rests on a question of viral genomics: one chain of transmission, or many separate importations?
AI Can Call Drug Resistance in Hours. Should Labs Trust It Yet?
AI diagnostics can now predict antibiotic and antiviral resistance from a pathogen genome with striking accuracy. We examine the 2026 evidence, and why Europe's own susceptibility testing committee says it is not ready for the clinic.
No Federal AI Law? How US States Are Quietly Writing the Rules for Health AI
The US still has no federal AI law. We map how state AI laws now govern health AI, from chatbot crisis rules to human review of insurance denials, and what federal preemption could change.
AI-Designed Longevity Drugs Are in Human Trials. Do Any of Them Work?
AI drug discovery has put the first ageing-focused drugs into human trials. We weigh the evidence on rentosertib, BGE-102, RLS-1496 and the ageing clocks used to judge them.
AI in Healthcare
See allAI Can Call Drug Resistance in Hours. Should Labs Trust It Yet?
AI diagnostics can now predict antibiotic and antiviral resistance from a pathogen genome with striking accuracy. We examine the 2026 evidence, and why Europe's own susceptibility testing committee says it is not ready for the clinic.
